Clinical Trial Update: A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing optimized recombinant human thrombopoietin (rhTPO) versus eltrombopag in patients with previously treated primary immune th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)
• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Previously Treated Primary Immune Thrombocytopenia | Phase 4 | Status: COMPLETED